Clinical Implications of ALDH1L1 Expression in Hormone Receptor-Positive Breast Cancer

1,086 breast cancer patient samples from Seoul National University Hospital cohorts were analyzed for ALDH1L1 expression via immunostaining. The dataset includes clinical data on tumor size, grade, lymphatic invasion, and lymph node metastasis, and links expression levels to survival outcomes. It was authored by Han Suk Ryu and last updated on 2026-05-25.

Use Cases

• Predicting patient survival outcomes based on ALDH1L1 expression levels mentioned in the description
• Analyzing correlations between biomarker expression and tumor aggressiveness features like size and stage
• Identifying subtype-specific therapeutic targets for hormone receptor-positive breast cancer

Strengths

• Includes data from 1,086 patient cases across three cohorts
• Links biomarker expression to clinical outcomes like overall and disease-free survival

Limitations

• Column-level documentation is absent; field semantics must be inferred after download
• Row count is unknown, which may limit suitability assessment

Provenance

Source

Seoul National University Hospital cohorts

Collection Method

Immunostaining performed on tissue microarrays or whole section slides, with clinical data collected from patient records

Freshness

Last updated 2026-05-25 04:34:00

Geography

Seoul, South Korea (likely)